136 related articles for article (PubMed ID: 3671821)
1. Caregiver perceptions of psychotropic medication in residential facilities.
Aman MG; Singh NN; White AJ
Res Dev Disabil; 1987; 8(3):449-65. PubMed ID: 3671821
[TBL] [Abstract][Full Text] [Related]
2. The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded.
Aman MG; Singh NN; Fitzpatrick J
J Autism Dev Disord; 1987 Dec; 17(4):511-23. PubMed ID: 3680153
[TBL] [Abstract][Full Text] [Related]
3. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
[TBL] [Abstract][Full Text] [Related]
4. Direct service staff and their perceptions of psychotropic medication in non-institutional settings for people with intellectual disability.
Christian L; Snycerski SM; Singh NN; Poling A
J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():88-93. PubMed ID: 10221788
[TBL] [Abstract][Full Text] [Related]
5. Problem behavior and psychiatric impairment within a developmentally disabled population. III: Psychotropic medication.
Jacobson JW
Res Dev Disabil; 1988; 9(1):23-38. PubMed ID: 3353539
[TBL] [Abstract][Full Text] [Related]
6. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies for self-injurious behavior in a large service-delivery network.
Altmeyer BK; Locke BJ; Griffin JC; Ricketts RW; Williams DE; Mason M; Stark MT
Am J Ment Defic; 1987 Jan; 91(4):333-40. PubMed ID: 3812603
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic-based pharmacological treatment of behavior disorders in persons with developmental disabilities: a review and a decision-making typology.
Sturmey P
Res Dev Disabil; 1995; 16(4):235-52. PubMed ID: 7480954
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prediction of psychotropic drug use in California developmental centers.
Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
[TBL] [Abstract][Full Text] [Related]
11. Structured Medication Review to Improve Pharmacotherapy in People with Intellectual Disability and Behavioural Problems.
Scheifes A; Egberts TC; Stolker JJ; Nijman HL; Heerdink ER
J Appl Res Intellect Disabil; 2016 Jul; 29(4):346-55. PubMed ID: 25882186
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic drugs and mental retardation: 1. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings.
Clarke DJ; Kelley S; Thinn K; Corbett JA
J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():385-95. PubMed ID: 2266549
[TBL] [Abstract][Full Text] [Related]
13. Mental retardation: state of the field in New Zealand.
Singh NN; Aman MG
Appl Res Ment Retard; 1981; 2(2):115-27. PubMed ID: 7052751
[No Abstract] [Full Text] [Related]
14. Drug use management in board and care facilities.
Garrard J; Cooper SL; Goertz C
Gerontologist; 1997 Dec; 37(6):748-56. PubMed ID: 9432991
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
Meins W; Auwetter J; Krausz M; Turnier Y
Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
Martin JE; Agran M
Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
[TBL] [Abstract][Full Text] [Related]
17. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
19. Brief report: reliability and validity of instruments for assessing psychotropic medication effects on self-injurious behavior in mental retardation.
Schroeder SR; Rojahn J; Reese RM
J Autism Dev Disord; 1997 Feb; 27(1):89-102. PubMed ID: 9018584
[No Abstract] [Full Text] [Related]
20. Psychotropic drug use in older developmentally disabled with behavioral difficulties.
Harper DC; Wadsworth JS; Michael AL
Res Dev Disabil; 1989; 10(1):53-60. PubMed ID: 2928579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
